Eisai

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
Pharma Voice
Tue, 03/4/25 - 09:51 am
Voyager Therapeutics
RNA
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Australia stands firm on 'no' to Alzheimer's drug Leqembi
Pharmaphorum
Mon, 03/3/25 - 10:53 am
Eisai
Biogen
Australia
Alzheimer's disease
Leqembi
Leqembi, after delay, gets back on track toward EU approval
BioPharma Dive
Sun, 03/2/25 - 09:35 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Europe
Eisai to part ways with 121 employees amid new US restructuring effort
Fierce Pharma
Thu, 02/27/25 - 09:29 pm
Eisai
restructuring
layoffs
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym
Fierce Pharma
Tue, 02/11/25 - 09:41 pm
Eisai
Leqembi
Alzheimer's disease
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Marketscreener
Fri, 01/31/25 - 11:16 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales
BioPharma Dive
Mon, 01/27/25 - 11:24 am
Biogen
Eisai
Leqembi
Alzheimer's disease
FDA
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Fierce Pharma
Fri, 01/24/25 - 11:30 am
Merck
Eisai
clinical trials
Keytruda
Lenvima
gastroesophageal adenocarcinoma
GI cancers
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
Clinical Trials Arena
Fri, 01/10/25 - 11:18 am
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Alzheon
Eisai unit hands over $46M for Japanese rights to Newron’s schizophrenia add-on
Fierce Biotech
Sun, 12/15/24 - 10:48 pm
Newron Pharma
Eisai
schizophrenia
evenamide
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome
Fierce Pharma
Mon, 11/18/24 - 06:36 pm
Eisai
obesity
lorcaserin
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Eisai
earnings
Leqembi
Alzheimer's disease
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Eisai
Biogen
Leqembi
Alzheimer's disease
FDA
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Fierce Pharma
Mon, 10/14/24 - 11:13 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype
Fierce Pharma
Sun, 09/15/24 - 06:30 pm
ESMO
Merck
Eisai
Keytruda
Lenvima
liver cancer
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease
Eisai plants molecular glue SEED with $1.5B biobucks deal in neuro, oncology
Fierce Biotech
Tue, 08/6/24 - 11:14 am
Eisai
molecular glue
biobucks
Seed Therapeutics
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe

Pages